Inhibitors of Hepatitis C virus

Compounds of Formula I are disclosed, as well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical 5 compositions containing said compounds are also disclosed.

Saved in:
Bibliographic Details
Main Authors Kobayashi, Tetsuya, Schrier, Adam James, Vivian, Randall W, Zipfel, Sheila, Canales, Eda, Martin, Teresa Alejandra Trejo, Kato, Darryl, Bjornson, Kyla, Yang, Zheng-Yu, Cottell, Jeromy J, Martinez, Ruben, Pyun, Hyung-jung, Tran, Chinh Viet, Sangi, Michael, Zablocki, Jeff, Katana, Ashley Anne, Siegel, Dustin, Karki, Kapil Kumar, Link, John O, Taylor, James G, Phillips, Barton W
Format Patent
LanguageEnglish
Published 06.06.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula I are disclosed, as well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical 5 compositions containing said compounds are also disclosed.
Bibliography:Application Number: AU20170203984